JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2008; 51:37-45, doi:10.1016/j.jacc.2007.06.063
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Afilalo, J.
Right arrow Articles by Eisenberg, M. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Afilalo, J.
Right arrow Articles by Eisenberg, M. J.
Related Collections
Right arrowRelated Articles

CLINICAL RESEARCH: LIPIDS AND ATHEROSCLEROSIS

Statins for Secondary Prevention in Elderly Patients

A Hierarchical Bayesian Meta-Analysis

Jonathan Afilalo, MD*, Gustavo Duque, MD, PhD*,{dagger}, Russell Steele, PhD{ddagger}, J. Wouter Jukema, MD, PhD§, Anton J.M. de Craen, PhD|| and Mark J. Eisenberg, MD, MPH*,1,*

* Department of Medicine, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Canada
{dagger} Division of Geriatrics and Bloomfield Center for Aging Research, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Canada
{ddagger} Department of Mathematics and Statistics, McGill University, Montreal, Canada
§ Division of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
|| Division of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, Netherlands
Divisions of Cardiology and Clinical Epidemiology, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Canada.

Manuscript received April 9, 2007; revised manuscript received May 31, 2007, accepted June 25, 2007.

* Reprint requests and correspondence: Dr. Mark J. Eisenberg, 3755 Cote Ste Catherine, Suite A-118, Montreal, Quebec H3T 1E2, Canada. (Email: mark.eisenberg{at}mcgill.ca).

Objectives: This study was designed to determine whether statins reduce all-cause mortality in elderly patients with coronary heart disease.

Background: Statins continue to be underutilized in elderly patients because evidence has not consistently shown that they reduce mortality.

Methods: We searched 5 electronic databases, the Internet, and conference proceedings to identify relevant trials. In addition, we obtained unpublished data for the elderly patient subgroups from 4 trials and for the secondary prevention subgroup from the PROSPER (PROspective Study of Pravastatin in the Elderly at Risk) trial. Inclusion criteria were randomized allocation to statin or placebo, documented coronary heart disease, ≥50 elderly patients (defined as age ≥65 years), and ≥6 months of follow-up. Data were analyzed with hierarchical Bayesian modeling.

Results: We included 9 trials encompassing 19,569 patients with an age range of 65 to 82 years. Pooled rates of all-cause mortality were 15.6% with statins and 18.7% with placebo. We estimated a relative risk reduction of 22% over 5 years (relative risk [RR] 0.78; 95% credible interval [CI] 0.65 to 0.89). Furthermore, statins reduced coronary heart disease mortality by 30% (RR 0.70; 95% CI 0.53 to 0.83), nonfatal myocardial infarction by 26% (RR 0.74; 95% CI 0.60 to 0.89), need for revascularization by 30% (RR 0.70; 95% CI 0.53 to 0.83), and stroke by 25% (RR 0.75; 95% CI 0.56 to 0.94). The posterior median estimate of the number needed to treat to save 1 life was 28 (95% CI 15 to 56).

Conclusions: Statins reduce all-cause mortality in elderly patients and the magnitude of this effect is substantially larger than had been previously estimated.

Abbreviations and Acronyms
  CHD = coronary heart disease
  CI = credible interval
  MI = myocardial infarction
  QUOROM = Quality of Reporting of Meta-Analyses of Randomised Controlled Trials
  RCT = randomized controlled trial
  RR = relative risk


Related Articles

Prevention and Treatment: A Tale of Two Strategies
George A. Diamond and Sanjay Kaul
J. Am. Coll. Cardiol. 2008 51: 46-48. [Full Text] [PDF]

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 51: A33-A34. [Full Text] [PDF]



This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
V. Bittner, D. Herrington, and N. Wenger
Analyzing the Results of the Treating to New Targets Study
Ann Intern Med, February 19, 2008; 148(4): 322 - 323.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. A. Diamond and S. Kaul
Prevention and treatment: a tale of two strategies.
J. Am. Coll. Cardiol., January 1, 2008; 51(1): 46 - 48.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2008 by the American College of Cardiology Foundation.